Liraglutide protects cardiac function in diabetic rats through the PPARα pathway

Increasing evidence shows that diabetes causes cardiac dysfunction. We hypothesized that a glucagon-like peptide-1 (GLP-1) analog, liraglutide, would attenuate cardiac dysfunction in diabetic rats. A total of 24 Sprague–Dawley (SD) rats were divided into two groups fed either a normal diet (normal,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qian, Xiao, Xinhua, Zheng, Jia, Li, Ming, Yu, Miao, Ping, Fan, Wang, Tong, Wang, Xiaojing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857913/
https://www.ncbi.nlm.nih.gov/pubmed/29440457
http://dx.doi.org/10.1042/BSR20180059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857913/
https://www.ncbi.nlm.nih.gov/pubmed/29440457
http://dx.doi.org/10.1042/BSR20180059

Ejemplares similares